| Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery E Toumi, B Goutorbe, A Plauzolles, M Bonnet, S Mezouar, M Militello, ... Frontiers in immunology 13, 943241, 2022 | 29 | 2022 |
| Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives E Toumi, S Mezouar, A Plauzolles, L Chiche, N Bardin, P Halfon, JL Mege Lupus science & medicine 10 (1), e000776, 2023 | 14 | 2023 |
| Human stool preservation impacts taxonomic profiles in 16S metagenomics studies A Plauzolles, E Toumi, M Bonnet, G Pénaranda, G Bidaut, L Chiche, ... Frontiers in Cellular and Infection Microbiology 12, 722886, 2022 | 10 | 2022 |
| Maternal immune factors involved in the prevention or facilitation of neonatal bacterial infections Y Sereme, E Toumi, E Saifi, H Faury, D Skurnik Cellular Immunology 395, 104796, 2024 | 7 | 2024 |
| Human stool preservation impacts taxonomic profiles in 16S rRNA gene-based metagenomics studies A Plauzolles, E Toumi, B Goutorbe, M Bonnet, G Pénaranda, G Bidaut, ... | 1 | 2020 |
| A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens E Kramarska, E Toumi, F Squeglia, D Laverde, V Napolitano, E Frapy, ... npj Vaccines 9 (1), 151, 2024 | | 2024 |
| OP27 Oxalyl-CoA decarboxylase is a major and specific virulence factor for Adherent Invasive Escherichia coli E Toumi, G Orianne, C Reisacher, N Rolhion, H Sokol, D Skurnik Journal of Crohn's and Colitis 18 (Supplement_1), i48-i48, 2024 | | 2024 |
| Urinary soluble CD163: a non-invasive biomarker to monitor lupus nephritis E Toumi, N Jourde-Chiche, M Tailliar, S Mezouar, A Bouamri, D Bertin, ... | | 2022 |
| Lupus érythémateux systémique: étude du microbiote intestinal et enjeux thérapeutiques E Toumi Aix-Marseille, 2022 | | 2022 |
